Zenith Drugs Limited

About the company

## **About  Zenith Drugs Limited** Incorporated in 2000, Drugs Limited pharmaceutical manufacturing and trading company based out from Indore. They have a manufacturing unit, dedicated to ensuring the highest quality standards when it comes to manufacturing of medicines. They  specialised in manufacturing high quality and affordable Medicines to support their patients in need. The Company is also into Generic Medicines and Generic Medicines are cost effective. Since its inception the company has focused on building a strong foundation and laying the groundwork for their future growth and success. With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry. The Company was incorporated with the objective of better service deliverance in the field of medicine and to be better premium pharmaceutical companies in India and abroad for cost effective human medicine. The Company always emphasises core strength and policies that focus on technology and great deliverance. With a passion to set high standards of services, the company has always taken all measures to scale up as and when required only to deliver the best. They work diligently and have a wide range of products to cater to every need and to reach the client sensitivity and centricity. As Zenith Drugs Limited  prepares for its highly anticipated Initial Public Offering (IPO), the company has meticulously outlined the strategic allocation of proceeds from the Fresh Issue to ensure optimal utilization and sustainable growth. * Purchase of Machinery & Equipments for Setting up New Unit  *  Existing Manufacturing Block Upgradation  *  Working Capital Requirements  *  General Corporate Purposes Here are key details about the Zenith Drugs Limited IPO: Company Name| **Zenith Drugs Limited**|  | Zenith Drugs Limited IPO Opening Date| **February 19, 2024** ---|---|---|---|--- Company Established On|**2000**Zenith Drugs Limited IPO Price band|**₹75 to ₹79 per share**

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   19 Feb 2024

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   22 Feb 2024

   Last day to place your bid

3. Basis of Allotment

   Completed
   21 Feb 2024

   Share allotment finalised

4. Refund Initiation

   Completed
   26 Feb 2024

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   23 Feb 2024

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   27 Feb 2024

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.